Previous Article | Next Article 
J Bacteriol, April 1998, p. 1682-1690, Vol. 180, No. 7
0021-9193/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Characterization of the bvgR Locus of
Bordetella pertussis
Tod J.
Merkel,1,*
Cassia
Barros,1 and
Scott
Stibitz2
National Institute of Dental Research,
National Institutes of Health,1 and
Center for Biologics Evaluation and Research, U.S. Food and
Drug Administration,2 Bethesda, Maryland 20892
Received 17 October 1997/Accepted 24 January 1998
 |
ABSTRACT |
Bordetella pertussis, the causative agent of whooping
cough, produces a wide array of factors that are associated with its ability to cause disease. The expression and regulation of these virulence factors is dependent upon the bvg locus
(originally designated the vir locus), which encodes two
proteins: BvgA, a 23-kDa cytoplasmic protein, and BvgS, a 135-kDa
transmembrane protein. It is proposed that BvgS responds to
environmental signals and interacts with BvgA, a transcriptional
regulator which upon modification by BvgS binds to specific promoters
and activates transcription. An additional class of genes is repressed
by the bvg locus. Expression of this class, the
bvg-repressed genes (vrgs [for vir-repressed
genes]), is reduced under conditions in which expression of the
aforementioned bvg-activated virulence factors is maximal;
this repression is dependent upon the presence of an intact
bvgAS locus. We have previously identified a locus required for regulation of all of the known bvg-repressed genes in
B. pertussis. This locus, designated bvgR, maps
to a location immediately downstream of bvgAS. We have
undertaken deletion and complementation studies, as well as sequence
analysis, in order to identify the bvgR open reading frame
and identify the cis-acting sequences required for regulated expression of bvgR. Studies utilizing
transcriptional fusions of bvgR to the gene encoding
alkaline phosphatase have demonstrated that bvgR is
activated at the level of transcription and that this activation is
dependent upon an intact bvgAS locus.
 |
INTRODUCTION |
Whooping cough is an acute
respiratory disease caused by the small gram-negative bacterium
Bordetella pertussis. B. pertussis expresses several factors
that contribute to its ability to cause disease (15, 16, 33, 43,
45). Several of these factors, including filamentous
hemagglutinin, pertactin, fimbriae, and the recently described tracheal
colonization factor, contribute to the interaction between the
bacterium and host cells. Other virulence factors are exotoxins which
impair the function of immune cells and/or are capable of causing
damage to host tissues. These include pertussis toxin, adenylate
cyclase toxin, dermonecrotic toxin, and tracheal cytotoxin. Expression
of these virulence factors, with the exception of tracheal cytotoxin,
is activated at the level of transcription by a single locus, referred
to as the bvg locus (originally designated the
vir locus) (3, 38, 39, 42, 44). The
bvg locus encodes a two-component regulatory system
consisting of a sensor protein, BvgS, and a transcriptional activator,
BvgA. Although the relevant signals for regulation of the
bvg locus in vivo are unknown, activity of the
bvg locus is repressed when cells are grown in the presence
of MgSO4 or nicotinic acid or when they are grown at a
reduced temperature in vitro (26). This
bvg-mediated change in the patterns of transcription in
response to environmental signals is referred to as phenotypic modulation. Under nonmodulating conditions, autophosphorylation of BvgS
on a conserved histidine residue is followed by two intramolecular phosphotransfer reactions and the transfer of the phosphate moiety to a
conserved aspartate residue on BvgA (41). Upon
phosphorylation by BvgS, BvgA binds to cis-acting sequences
in the promoter regions of the bvg-activated genes and
activates transcription (7, 8, 22).
In addition to the virulence factors which are activated by the
bvg locus, a second class of genes, which is repressed by the bvg locus, has been described (24). The
function(s) of the bvg-repressed genes is unknown. The fact
that these genes are repressed by the locus responsible for regulation
of known virulence genes suggests that they play a role in the
pathogenesis of the bacterium, perhaps by contributing to late stages
in the infectious cycle. Alternatively, their inappropriate expression
may interfere with the bacterium's ability to cause disease. Five
bvg-repressed genes have been identified to date
(vrg6, vrg18, vrg24, vrg53, and vrg73), and the DNA sequences of the 5' ends of these
genes have been determined (4, 5). Examination of the
upstream regions of these genes revealed the presence of a conserved
sequence element in four of the five genes (vrg6,
vrg18, vrg24, and vrg53). The
exception, vrg73, does not appear to contain this element. A
6-bp linker inserted into the conserved sequence element, as well as a
single base pair change within the element in one of these genes,
vrg6, eliminated responsiveness to modulation and resulted
in constitutive expression (4, 5). A construct in which the
sequences upstream of the initiating codon in vrg6 were
replaced with a constitutive B. pertussis promoter was still regulated normally, demonstrating that the cis-acting
sequences required for bvg-dependent repression of this
locus are located downstream of the translation start site
(5). The conserved sequence element in vrg6 was
shown by Southwestern analysis to be bound by a 34-kDa protein which is
present in nonmodulated cells but absent in modulated cells
(5). These results, taken together, have led to a proposed
model of bvg repression in which the
bvg-repressed genes are regulated by a repressor protein, the expression or activity of which is activated by the bvg
locus. A locus required for expression of repressor activity has been identified and shown to be located immediately downstream of the bvgS gene (30). This locus has been designated
bvgR.
In this report, we describe the identification and characterization of
the BvgR open reading frame. The presence of several errors in the
published sequence of the region downstream of bvgS resulted
in a failure to recognize previously the presence of this large open
reading frame in the bvg locus (3). Analysis of
the corrected sequence, presented herein, and the results of complementation analyses demonstrate that the bvgR gene is
located immediately downstream of bvgS and that it is
transcribed convergently to bvgAS. Activation of expression
of the bvgR gene by BvgA was demonstrated to be at the level
of transcription.
 |
MATERIALS AND METHODS |
Bacterial strains, plasmids, oligonucleotides, and media.
The bacterial strains and plasmids used in this study are presented in
Table 1. Escherichia coli
strains were grown on L agar or in L broth supplemented with
antibiotics when appropriate (31). B. pertussis
strains were grown on Bordet-Gengou agar (Difco) containing 1%
proteose peptone (Difco) and 15% defibrinated sheep blood.
Concentrations of antibiotics, unless stated otherwise, were as
follows: gentamicin sulfate, 10 µg/ml; kanamycin sulfate, 10 µg/ml;
nalidixic acid, 50 µg/ml; rifampin, 50 µg/ml; streptomycin sulfate,
100 µg/ml. Plasmids were transformed into E. coli DH5
(Bethesda Research Laboratories, Bethesda, Md.).
Strain and plasmid construction.
pTM193 derivatives bearing
B. pertussis chromosomal fragments derived from the region
downstream of the bvgA and bvgS genes were
constructed as follows. Oligonucleotides MCS-1
(5'-CGCCG CGGATCCATATGAGCTC TAGATC TAG TAC TAG TCGACCATGG TACCAATTGAATTCGCTAGCATGC-3') and MCS-2
(5'-CGGCATGCTAGCGAAT TCAAT TGGTACCATGG TCGAC TAG TAC TAGATC TAGAGC TCATATGGATCCGCGG-3')
were annealed to generate a linker bearing the restriction enzyme
sites NarI, SacII, BamHI, NdeI, SacI, XbaI, BglII,
ScaI, SpeI, SalI, HincII,
NcoI, KpnI, MunI, EcoRI,
NheI, SphI, and NarI. This linker was
cloned into the NarI site of plasmid pBBRKAN to generate
plasmid pTM193. The 9.0-kb BglII-BamHI, 6.0-kb
SalI, 4.0-kb XhoI, 3.5-kb
BglII-XhoI, or 1.3-kb
SalI-XhoI restriction fragment derived from the
region downstream of the bvg locus was cloned into the
multiple cloning site of plasmid pTM193 to generate plasmids
pTM193:BgB, pTM193:S, pTM193:X, pTM193:BgX, and pTM193:SX,
respectively. Restriction fragments bearing BglII-proximal
deletions of the 3.5-kb BglII-XhoI fragment were
generated by PCR with primers X1
(5'-CTGACTCGAGAATGGCCTGCCGGTCCGCCACATCGAGCAG-3'), and either
Bg2 (5'-GTCAAGATCTGGCTACGAATTGGCGCGCCGCATACGCGCC-3'), Bg3
(5'-GTCAAGATCTGGCCGAAGGTCTCGGACATGGCGCACAGGC-3'), Bg4
(5'-GTCAAGATCTTGGTACGTACGCTTGCGGCGCAGTCCGCCG-3'), Bg5
(5'-GTCAAGATCTCCTTACGGATAATTGGGCGGCATCTCGCGG-3'), or Bg6
(5'-GTCAAGATCTCATGGGCGGGGCCACATGGTCGCCCAGCAG-3'). Restriction fragments bearing XhoI-proximal deletions
of the 3.5-kb BglII-XhoI fragment were generated
by PCR with primers Bg1
(5'-GACTAGATCTCGAGAATGGCCTGCCGGTCCGCCACATC-3') and either X2
(5'-GTCACTCGAGCGCTGGTGGTTTCGATGCGGCCGCTGAAGG-3'), X3
(5'-GTCACTCGAGGCGACCCCGCATTGATCGGTATCGCCGACC-3'), X4
(5'-GTCACTCGAGCGGCCACATGCTGGTCACCGATCTGCTCAAC-3'), or X5
(5'-GTCACTCGAGCATGATCCACTGGACCAACAGCGCTCGCAG-3'). The
products of these PCRs were double-stranded DNA fragments which
contained terminal BglII and XhoI restriction
enzyme sites. After digestion with BglII and
XhoI, these fragments were inserted into plasmid pTM193,
which had been digested with BglII and SalI.
Although the entire sequences of the PCR products were not determined, at least four independent PCRs were performed to generate those products and the PCR products from each reaction gave the same result,
indicating that differences in activity between the truncated DNA
fragments generated by PCR and the full-length wild-type fragment are
consequences of the deletion of required sequences at the termini
rather than results of misincorporation of nucleotides during the
extension reactions.
Strains with transcriptional fusions of the E. coli gene for
alkaline phosphatase (phoA) to open reading frames
downstream of bvgAS were constructed as follows.
Oligonucleotide XApX (5'-TCGAGGGCCC-3') was self-annealed to
generate a linker which permits the insertion of an ApaI
site into an XhoI site. This linker was inserted into the
XhoI site in plasmid pBS KS+, generating plasmid
pBS:XApX. The BglII-BamHI fragment from the B. pertussis bvg locus was inserted into plasmid pSS2000 to
generate plasmid pTM030. Plasmid pTM030 was digested with
BglII, XhoI, and mung bean nuclease and religated
to generate plasmid pTM057. A double-stranded DNA fragment bearing the
E. coli phoA gene was synthesized by PCR with primers phoA1
(5'-GCGGATCCGTATTTGTACATGGAGAAAATAAAATGAAACAAAGCAC-3') and
phoA2 (5'-GCGGATCCTTATTTCAGCCCCAGAGCGGCTTTCATGG-3'). This PCR resulted in the production of an altered form of the
phoA gene in which the native GTG initiating codon was
replaced by an ATG initiating codon. Oligonucleotides phoA1 and phoA2
both contain a BamHI restriction enzyme site, allowing
insertion of the phoA-bearing PCR product into the
BamHI site of plasmid pBS:XApX. This fragment can be
inserted in either of two possible orientations, generating plasmids
pTM073 and pTM074. The phoA gene was transferred from
plasmid pTM073 as an ApaI fragment into the ApaI
site of plasmid pTM057. Clones containing the phoA fragment
were identified and designated either pTM092 or pTM093, depending on
the orientation of the inserted DNA fragment. E. coli SM10
bearing pTM092 or pTM093 was mated with B. pertussis BP907
and BP947, as described below, and exconjugates in which the plasmid
sequences had integrated into the chromosome were isolated by selection
with gentamicin. Isolates in which plasmid sequences were lost from the
chromosome but in which the orf1-phoA or
orf2-phoA transcriptional fusion was retained were isolated
by selection for streptomycin resistance on Bordet-Gengou agar plates
and by screening for alkaline phosphatase activity in the absence of
modulators. PhoA+ Strr exconjugates of BP907
bearing the orf1-phoA and orf2-phoA fusions, as
well as PhoA+ Strr exconjugates of BP947
bearing the orf1-phoA and orf2-phoA fusions, were
isolated and have been designated TM1312, TM1311, TM1316, and TM1315,
respectively (Fig. 1).

View larger version (19K):
[in this window]
[in a new window]
|
FIG. 1.
B. pertussis TM1311, TM1312, TM1315, and
TM1316. The orf1-phoA transcriptional fusion present in
strains TM1312 and TM1316 and the orf2-phoA transcriptional
fusion present in strains TM1311 and TM1315 are shown. The putative
BvgR (ORF1 and ORF2) coding sequences are represented by black boxes.
The 3' terminus of the bvgS coding sequence is represented
by gray boxes. The alkaline phosphatase coding sequence is represented
by open boxes. The putative directions of transcription of the native
genes and transcriptional fusions are indicated by arrows. Restriction
enzyme recognition sequences are indicated as follows: E,
EcoRI; B, BamHI; S, ScaI; X,
XhoI; N, NcoI; A, ApaI.
|
|
Bacterial conjugations.
Matings between E. coli
and B. pertussis strains were performed by swabbing bacteria
from fresh plate cultures of each strain onto a Bordet-Gengou agar
plate supplemented with 10 mM MgCl2 but without any
antibiotics. After 3 h of incubation at 37°C, bacteria were
swabbed onto Bordet-Gengou agar containing the appropriate antibiotics
for selection of exconjugates, and incubation was continued at 37°C.
Prior to mating, B. pertussis strains were grown for 3 days
and E. coli strains were grown overnight at 37°C.
Quantitative alkaline phosphatase and
-galactosidase
assays.
Bacteria to be assayed were recovered by sterile swabs
into 3.5 ml of Tris-HCl, pH 8.0, and the absorbance at 600 nm was
measured. For measurement of
-galactosidase activity, 0.05 ml of
cell suspension was added to 1 ml of Z buffer, cells were permeabilized
by the addition of 30 µl of 0.1% sodium dodecyl sulfate and 30 µl
of chloroform followed by vortexing, and the assay was completed as
described by Miller (31). For measurement of alkaline
phosphatase, 0.5 ml of cell suspension was added to 0.5 ml of Tris-HCl
(pH 8.0), the cells were permeabilized as above, and the assay was completed as described by Brickman and Beckwith (9). Units in both cases were defined by the following equation: Units = [1,000 × A420
(1.75 × A550)]/(T × V × A600) where T is the incubation time, in
minutes, and V is the volume of permeabilized cells added to
the assay mixture, in milliliters.
Sequence analysis.
DNA fragments cloned in plasmid pBS
KS+ were sequenced by the dideoxy sequencing method with
the Sequenase 7-deaza dGTP DNA sequencing kit (United States
Biochemical, Cleveland, Ohio). Computer analysis of DNA and protein
sequences was performed with the GCG sequence analysis software package
(Genetics Computer Group Inc., Madison, Wis.) and with the MacVector
sequence analysis programs (International Biotechnologies Inc., New
Haven, Conn.).
 |
RESULTS |
Complementation studies of the bvgR locus.
We
identified previously a locus in B. pertussis that is
required for regulation of the bvg-repressed genes
(30). This locus, designated bvgR, was mapped to
a position immediately downstream of bvgAS. In order to
functionally define the limits of the bvgR locus, we
utilized the fact that bvgR-dependent regulation of a
vrg6-phoA fusion can be restored in the
bvgR-deficient strain TM1126 when the intact bvgR
locus is provided in trans (30). A collection of
restriction fragments containing different segments of DNA from the
region immediately downstream of bvgAS were cloned into
plasmid pTM193 (Fig. 2). These constructs
were transferred by conjugation into strain TM1126, which contains a
12-bp in-frame insertion within the bvgR locus, a
transcriptional fusion of the E. coli lacZ gene to the
bvg-activated gene fhaB, and a transcriptional fusion of the E. coli phoA gene to the
bvg-repressed gene vrg6. Quantitative enzyme
assays for alkaline phosphatase and
-galactosidase activities after
growth in either the presence or absence of 50 mM MgSO4
were performed in order to evaluate the ability of the exconjugates to
complement the bvgR deficiency in strain TM1126. In all of
the strains assayed, expression of the fha-lacZ fusion was
induced between 13- and 38-fold, indicating that the functions of BvgA
and BvgS were not altered in these constructs relative to the wild-type
strain. As seen previously, the activity of the vrg6-phoA
fusion in the wild-type strain shows an approximately 10-fold reduction
in activity when the cells are grown in the absence of
MgSO4, while the activity of the vrg6-phoA
fusion in strain TM1126 is reduced less than twofold under the same
conditions (Fig. 2A). Strain TM1126 bearing plasmid pTM193 alone or
pTM193:S, pTM193:X, or pTM193:SX failed to restore wild-type regulation of the vrg6-phoA fusion in strain TM1126 (Fig. 2A).
Introduction of plasmid pTM193:BgB or pTM193:BgX restored wild-type
regulation of the reporter fusion in strain TM1126. These results
indicated that the sequences required for regulated expression of BvgR
were located between the BglII site in bvgS and
the XhoI site 1.5 kb downstream of bvgS.

View larger version (23K):
[in this window]
[in a new window]
|
FIG. 2.
Deletion and complementation analysis of the
bvgR locus. The transcriptional activities of the
vrg6-phoA transcriptional fusions in wild-type (WT) strain
TM1081, strain TM1126, and strain TM1126 bearing the indicated pTM193
derivatives are shown. The bvg sequences inserted into the
multiple cloning site of each pTM193 derivative are indicated by solid
lines. (A) Effects of pTM193 alone and pTM193 bearing large restriction
fragments derived from the bvg locus on expression of the
vrg6 locus. (B) Effects of pTM193 bearing truncated versions
of the bvg BglII-XhoI restriction fragment on
expression of the vrg6 locus. The endpoints of deletions are
indicated in parentheses. Nucleotide numbers correspond to those in the
published sequence of bvgAS (3). Alkaline
phosphatase activities are reported relative to strain TM1081 grown in
the presence of MgSO4 (36.1 units). All reported values are
averages of at least six independent assays. Restriction enzyme
recognition sequences are indicated as follows: E, EcoRI; B,
BamHI; S, SalI; X, XhoI; Bg,
BglII.
|
|
In order to more precisely define the limits of the
bvgR
locus, a nested set of deletions of the
BglII-
XhoI fragment were
generated by PCR and DNA
fragments containing these deletions
were inserted into plasmid pTM193.
These constructs were transferred
by conjugation into strain TM1126,
and their ability to complement
the
bvgR deficiency in
strain TM1126 was determined. Deletion
of the sequences between the
BglII site and position 4447 in the
published sequence of
bvgAS did not effect the ability of the
plasmid to
complement the
bvgR deficiency in strain TM1126 (Fig.
2B).
However, a deletion extending to position 4576 eliminated
the ability
of the plasmid to provide
bvgR function in
trans.
Deletion of the sequences between the
XhoI site and position
5638
in the published sequence of
bvgAS did not affect the
ability
of the plasmid to complement the
bvgR deficiency in
strain TM1126;
however, a deletion of sequences up to position 5455 eliminated
the ability of the plasmid to provide
bvgR
function in
trans.
None of the
bvgR-bearing pTM193 derivatives conferred
constitutive repression of the
vrg6-phoA fusion in strain
TM1126. This
result indicates that there is not sufficient
transcriptional
activity through the multiple cloning site of the
plasmid to confer
expression of enough BvgR to repress transcription at
the
vrg6 locus. This conclusion is supported by the fact
that insertion
of all DNA fragments yielded the same result regardless
of the
orientation of the insert within the plasmid vector (data not
shown). These results indicate that expression of the
bvgR
locus
carried on the pTM193 derivatives is being driven by the native
bvgR promoter rather than by promoters provided by the
vector.
These results indicate that the
cis-acting sequences
required
for the regulated expression of
bvgR are located
between positions
4447 and 5638 of the published
bvgAS
sequence.
Sequencing of the bvgR locus.
A previous
examination of the published sequence of the region immediately
downstream of the bvgAS genes revealed three open reading
frames which were disrupted by all of the mutations known to eliminate
repressor activity in B. pertussis (30). Although the work of Beattie et al. (5) suggested that the
bvg-dependent repressor was a protein of approximately 34 kDa, none of the open reading frames downstream of bvgS were
predicted to encode a protein of that size. In addition, the boundaries
of the bvgR locus, as determined by deletion and
complementation analysis, were mapped to positions nearly 200 bp
downstream from the ends of any of the three predicted open reading
frames. In order to examine the possibility that the region defined by
the deletion and complementation analysis contained an open reading
frame large enough to encode a protein of approximately 34 kDa, we
determined the DNA sequence between the SalI site at
position 4272 in the published sequence and the XhoI site at
position 5991. We identified 8 nucleotide residues between the 3' end
of the bvgS gene and the XhoI site downstream of
bvgS which were in error in the published sequence (see Fig.
3). Sequencing was performed on both strands of DNA for the entire
region specified above. Nucleotides which were not in agreement with
the published sequence were sequenced at least two times on each
strand. Thus, a total of at least four independent sequencing reactions
were performed, and the readings for each corrected nucleotide were in
agreement in all of the reactions. Examination of the corrected
sequence revealed the presence of two open reading frames predicted to
encode proteins of approximately 30 kDa (Fig. 1). Open reading frame 1 (ORF1) extends from position 547 to position 1422 in the corrected
sequence (Fig. 3) and is predicted to
encode a 32-kDa protein. Open reading frame 2 (ORF2) extends from
position 1347 to position 520 in the corrected sequence and is
predicted to encode a 29-kDa protein. Transcription of ORF1 and
bvgAS is predicted to occur convergently. Sequences which
are good matches to the E. coli ribosomal binding site and
the E. coli
10 promoter element are found upstream of ORF1
at positions 474 to 479 and positions 510 to 516, respectively. ORF2
and bvgAS are predicted to be transcribed in the same
direction. Sequences which are good matches to the E. coli
ribosomal binding site and
10 promoter element are also found
upstream of ORF2, at positions 1379 to 1373 and 1417 to 1412, respectively.

View larger version (45K):
[in this window]
[in a new window]
|
FIG. 3.
Nucleotide sequence of bvgR. The nucleotide
sequence of bvgR and the 3' end of bvgS and the
corresponding amino acids are shown. A potential promoter element
( 10) and ribosomal binding site (RBS) are indicated by boxed-in
sequences. Corrections of the published sequence are indicated as
follows: nucleotides that are deleted in the published sequence are
indicated by asterisks, and at those positions where a nucleotide was
inserted or substituted in the published sequence, the nucleotide
present in the published sequence is shown above the corrected
sequence.
|
|
Activation of bvgR.
In an effort to determine which of
the two open reading frames encodes the bvg-dependent
repressor, an ApaI fragment containing a promoterless
E. coli phoA gene was inserted in both orientations into the
ApaI site located at position 5853 of the published
bvgAS sequence (Fig. 1). This allowed construction of
transcriptional fusions of the phoA gene to ORF1 and ORF2.
These constructs were transferred by conjugation into strain BP947,
which contains a transcriptional fusion of the E. coli lacZ
gene to fha, and strain BP907, which contains an in-frame
deletion of the bvgA locus. The orientation of the
phoA gene with respect to the bvg locus was
determined by restriction enzyme digestion of plasmid DNA prior to
introduction into strains BP947 and BP907 and also by PCR analysis of
chromosomal DNA derived from strains TM1311, TM1312, TM1315, and TM1316
(data not shown). The activities of the bvg-phoA and
fha-lacZ fusions in each strain were determined by analysis of the exconjugates with quantitative enzyme assays for alkaline phosphatase and
-galactosidase after growth at 37°C. The results of this analysis are shown in Fig. 4. The
fha-lacZ fusions in strains TM1315 and TM1316 demonstrated
high levels of expression when the cells were grown in the absence of
modulators. This activity was reduced approximately 25-fold upon growth
of the cells in the presence of 50 mM MgSO4 or 20 mM
nicotinic acid and approximately 5-fold upon growth at 25°C (data not
shown). Low-level constitutive alkaline phosphatase activity was
detected under all of the conditions examined for the transcriptional
fusion of the phoA gene to ORF2 (orf2-phoA)
(strains TM1311 and TM1315). The transcriptional fusion of the
phoA gene to ORF1 demonstrated high levels of expression in
the wild-type background (strain TM1316) in the absence of modulators.
This expression was reduced approximately 6.5-fold when the bacteria
were grown in the presence of 50 mM MgSO4. The orf1-phoATG fusion demonstrated low-level constitutive
activity in strain TM1312, which bears an in-frame deletion of the
bvgA locus. We investigated the regulation of expression of
the orf1-phoA fusion further by determining the level of
alkaline phosphatase activity expressed in strain TM1316 after growth
in the presence of 20 mM nicotinic acid or after growth at 25°C, two
conditions that have also been shown to modulate the activity of
bvg-activated genes. The high level of alkaline phosphatase
activity seen in strain TM1316 upon growth in the absence of modulators
was reduced approximately 6.5-fold when the cells were grown in the
presence of 20 mM nicotinic acid and approximately 4-fold when the
cells were grown at 25°C.

View larger version (20K):
[in this window]
[in a new window]
|
FIG. 4.
Transcriptional activation of bvgR. Alkaline
phosphatase activities of transcriptional fusions of the E. coli gene encoding alkaline phosphatase to ORF1 and ORF2 are shown
after growth in the presence and absence of modulators. Black bars, no
modulator; dotted bars, 50 mM MgSO4; diagonally striped
bars, 20 mM nicotinic acid; white bar, growth at 25°C. Activities are
reported relative to strain TM1316 grown in the absence of
MgSO4 (153.26 units). All reported values are averages of
at least four independent assays.
|
|
These results demonstrate that expression of ORF1 is activated at the
level of transcription and that this expression is dependent
upon the
presence of an intact
bvgA locus. Moreover, this activity
is
reduced upon growth under conditions known to down-modulate
the
expression of
bvgA-activated genes. Our observations
indicate
that ORF1 encodes a
bvgA-activated protein. This,
along with the
result that only a low constitutive level of
transcriptional activity
was detected through ORF2 under conditions
known to promote expression
of
bvg-activated genes, has led
us to assign a
bvgR coding function
to ORF1.
Analysis of the bvgR sequence.
The predicted
protein sequence of BvgR was determined and compared to sequences in
the Swiss Protein, Protein Information Resource, and GenBank translated
sequence databases. A search of the databases with the BLAST program
showed that BvgR has significant homology to 18 proteins or predicted
proteins found in a variety of eubacterial organisms, although the
functions of these proteins are unknown (Fig.
5). The rtn locus of E. coli was identified by a transposon insertion that conferred an
increased rate of adaptive mutation (19). The mechanism by
which the rtn locus confers this phenotype, or if disruption
of the rtn open reading frame is even responsible for the
phenotype, has yet to be determined. The 22-kDa antigen of
Borrelia burgdorferi has been identified, but its function
is unknown (28). The functions of two of these predicted
proteins have only been inferred, based upon their sequence homologies
to characterized proteins in other organisms. These are the NifL
homolog of Synechocystis sp. and the FixL homolog of
E. coli (21) (D90789). It should be noted that
the homology between these predicted proteins and BvgR does not extend
to the characterized examples of these proteins (NifL of
Klebsiella pneumoniae and FixL of Rhizobium
meliloti). The functions of the remaining 14 of these predicted
proteins are unknown, although their open reading frames are within or
are tightly linked to operons with defined functions. Sequence
alignment by the LFASTA program initially showed that a region of 55 amino acid residues was highly conserved among 16 of the 19 proteins
(Fig. 5A). Domain I of BvgR is most closely related to domain I of
YAHA_ECOLI, with 31% identity and 47% similarity over the
55-amino-acid region. Alignment of the 15 protein sequences
identified as having homology to BvgR within domain I revealed the
presence of a second region of high sequence homology (Fig. 5B).
Although this family of proteins was originally defined by homology to
domain I of BvgR, BvgR itself shows very poor conservation of domain
II. Within this family, we have observed that in addition to the high
degree of sequence conservation within the two domains, the spacing
between the two domains and the distance between domain II and the
carboxy-terminal ends of the predicted proteins are also conserved.
(Fig. 5C). It should be noted that we have included in this analysis
only those proteins and predicted proteins for which some information
is available. An additional 12 open reading frames in the
Synechocystis genome, 9 open reading frames in the E. coli genome, and 2 open reading frames in the Mycobacterium
tuberculosis genome that contain these two conserved sequence
elements were identified, bringing the total number of potential
members of this protein family to 42.

View larger version (73K):
[in this window]
[in a new window]
|
FIG. 5.
Alignment of the predicted amino acid sequence of BvgR
with a new family of proteins. BVGR_BPER, predicted protein BvgR of
B. pertussis; YAHA_ECOLI, hypothetical 40.7-kDa protein
encoded by the betT 3' region of E. coli
(27); NIFL_SLL, NifL homolog of Synechocystis sp.
(21); STYRESORF, open reading frame 4 of the
Salmonella typhimurium resolvase operon (25);
FIMK_KPNEU, FimK protein of K. pneumoniae (17);
RTN_ECOLI, Rtn protein of E. coli (19, 20);
ISTN501ORF, unidentified reading frame 2 of the ISTN501-encoded
mercuric ion resistance operon of Pseudomonas aeruginosa
(10-12, 14, 32); ECOMERORF, unidentified reading frame 2 of
the E. coli mercuric ion resistance operon (R100) (1,
11); SFLMERORF, unidentified reading frame 2 of the
Shigella flexneri mercuric ion resistance operon
(Tn501) (11); SMAMERORF, unidentified reading
frame 2 of the Serratia marcesens mercuric ion resistance
operon (pDU1358) (18); FIXL_ECOLI, FixL homolog of E. coli (D90789); PHAX_RMEL, unidentified reading frame X of the
pha operon of R. meliloti (X93358); YNTC_AZOCA,
hypothetical 80.5-kDa protein encoded by the ntrC 5' region
of Azorhizobium caulinodans (34); YJCC_ECOLI,
hypothetical 60.8-kDa protein encoded by the ssb-soxS
intergenic region (6); YHJK_ECOLI, hypothetical 73.1-kDa
protein encoded by the dctA-dppF intergenic region
(36); YFEA_ECOLI, hypothetical protein encoded by the
gltX 5' region of E. coli (13, 46).
FCCORF_WOSU, unidentified open reading frame in the fcc 5'
region of Wolinella succinogenes (Y10581); DEFORF_CALO,
unidentified open reading frame in the def 3' region of
Calothrix sp. (29); 22AG_BBUG, 22-kDa antigen of
B. burgdorferi (28). Black boxes indicate
positions conserved in at least 51% of the aligned sequences.
|
|
Examination of the predicted BvgR sequence with the Motifs program did
not reveal the presence of any of the sequence motifs
defined in the
PROSITE dictionary of protein sites and patterns.
No sequences with
significant homologies were identified when
the predicted protein
sequence encoded by ORF2 was compared to
sequences in the Swiss
Protein, Protein Information Resource,
and GenBank translated sequence
databases with the BLAST program.
 |
DISCUSSION |
The locus required for regulation of the bvg-repressed
genes in B. pertussis is located immediately downstream of
bvgAS (30). This locus was designated
bvgR, for Bordetella virulence gene repression.
Examination of the published sequence of the bvgAS locus
revealed the presence of three open reading frames in the region
immediately downstream of bvgAS that are predicted to be affected by all of the mutations that have been demonstrated to abolish
repressor activity (30). The largest of these open reading frames is predicted to encode a protein of approximately 25 kDa. Previous results published by Beattie et al. have suggested that the
repressor protein that binds to the conserved sequence element in the
vrg6 gene is a protein of approximately 34 kDa
(5). It is possible that rather than repressing the
bvg-repressed genes directly, the product of the
bvgR locus may be required for the expression or activity of
the repressor protein. If, however, bvgR does encode the
repressor protein, then either the repressor is smaller than 34 kDa in
size or the bvgR open reading frame is larger than those
open reading frames present in the published sequence. In order to
begin to address these possibilities, we sought to functionally define
the upstream and downstream limits of the bvgR locus.
Various plasmid derivatives of plasmid pTM193 bearing sequences derived
from the bvgR locus were introduced into strain TM1126,
which bears an insertional mutation in the bvgR locus which
abrogates bvgR function. The ability of these derivatives to
provide bvgR function in trans was determined. This analysis allowed localization of the cis-acting
sequences required for regulated expression of bvgR to
between positions 4447 and 5639 in the published bvgAS
sequence. It should be noted, however, that although this system
provides an effective method for determining the boundaries of the
bvgR locus, it provides only an indirect measure of the
level of bvgR expression. It is possible, for example, that
promoter elements contributing to bvgR expression reside
upstream of position 5639, since a requirement for these sequences
would not be detected by the assay utilized in this study if less than
100% of bvgR expression was sufficient to fully activate
expression at the vrg6 locus. Future studies will focus on
the identification and characterization of all cis-acting sequences that contribute to bvgR expression.
Having determined the functional boundaries of the bvgR
locus, we next undertook the sequencing of the region between the end
of the bvgS open reading frame and the XhoI site
1.5 kb downstream of this site. This analysis resulted in the
identification of 8 nucleotides which were in error in the published
sequence (Fig. 3). Examination of the corrected sequence revealed the
presence of two large open reading frames downstream of bvgS
within the boundaries determined by deletion and complementation
analysis to be sufficient to provide bvgR activity in
trans (Fig. 3). One open reading frame (ORF2) was located
almost in its entirety within the other open reading frame (ORF1),
although the two open reading frames are encoded on opposite strands of
the DNA. Both open reading frames would be expected to be disrupted by
all of the mutations known to abolish repressor activity in B. pertussis, and both open reading frames are large enough to encode
the protein identified as the repressor protein in the studies of
Beattie et al. (5). The presence of two large open reading
frames immediately downstream of bvgAS, in opposite
orientation to each other, suggests two models for the regulated
transcription of bvgR. If bvgR is encoded by
ORF2, it lies immediately downstream of bvgS oriented in the same direction as bvgA and bvgS, which would
allow all three proteins to be expressed from a single transcript under
the regulation of the bvgAS promoter. If, however,
bvgR is encoded by ORF1, its transcription is presumably
driven from its own bvgA-activated promoter. Analysis of the
transcription in the region downstream of bvgS revealed that
there is only a low constitutive level of transcription through ORF2.
In contrast, there was a high level of transcriptional activity through
ORF1 that was reduced upon growth under conditions known to modulate
the expression of bvg-activated genes; this transcription
was dependent upon an intact bvgA locus. These results
demonstrate that ORF1, but not ORF2, encodes a bvg-activated gene and support the conclusion that bvgR is encoded by
ORF1. Although it remains to be demonstrated that bvgR
encodes the actual repressor of the bvg-repressed genes, the
fact that the product of the bvgR locus is predicted to be a
protein of 32 kDa is consistent with that conclusion. It is interesting
that the bvg-activated transcription of bvgA and
bvgS does not extend through the bvgR locus. This
is perhaps a little surprising, given that the end of bvgR
lies only 43 nucleotides downstream from bvgS. Examination of the sequence between bvgS and bvgR reveals the
presence of several large potential stem-loop structures. The presence
of one or more of these stem-loop structures may lead to
transcriptional termination in this region. Perhaps this is required in
order to ensure that overlapping transcription of bvgAS and
bvgR does not interfere with expression of the products of
these genes.
The predicted BvgR protein encoded by ORF1 contains a domain that is
strongly conserved among a large number of predicted proteins from a
variety of eubacterial species (Fig. 5). This family of predicted
proteins has been identified based on its homology to domain I of BvgR.
Most of the members of this family are characterized by two domains of
strong sequence homology which are located at the carboxy-terminal ends
of the proteins and which reside approximately 130 residues apart.
Several members of this family of proteins have either domain I or
domain II but not both. The assignment of BvgR to this family of
proteins is based on its high degree of conservation within domain I. In this region, BvgR is most closely related to YAHA_ECOLI, with 30%
identity and 46% similarity over the 55 residues. BvgR shows weak but
discernible conservation in domain II, suggesting that BvgR either has
lost the requirement for the function of Domain II or has adapted this domain for an alternative function. The functional role(s), if any, of
domain I and domain II is only speculative at this time, since no known
function has been demonstrated for any of the members of this protein
family. It is interesting to note that members of this family of
proteins are encoded by open reading frames which either lie within or
are very closely linked to functional operons. The identification and
characterization of BvgR allows, for the first time, the assignment of
an activity to one of the members of this family of proteins. It will
be interesting to evaluate whether the members of this family are
involved in regulation of expression of the operons to which they are
so closely linked.
In this study, we have identified the bvgR open reading
frame. The close correlation between the predicted size of the
bvgR product and the protein shown by Beattie et al.
(5) to bind the putative repressor binding site in the
vrg6 gene suggests that BvgR is the actual repressor protein
that binds to the conserved sequence element found within the coding
sequences of the bvg-repressed genes. Our results
demonstrate that the expression of bvgR is activated at the
level of transcription by the products of the bvgAS genes.
We propose that this activation is the result of binding of
phosphorylated BvgA to the bvgR promoter. Ongoing and future
work is and will be focused on characterizing in detail the activation
of bvgR expression and determining the mechanism by which
BvgR represses the expression of its target genes.
 |
ACKNOWLEDGMENT |
We thank Gopa Raychaudhuri for many helpful discussions and for
critical reading of the manuscript.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: OIIB/NIDR/NIH,
Building 30, Rm. 303, 30 Convent Dr. MSC 4350, Bethesda, MD 20892-4350. Phone: (301) 496-6060. Fax: (301) 402-0396. E-mail:
merkel{at}yoda.nidr.nih.gov.
 |
REFERENCES |
| 1.
|
Allmeier, H.,
B. Cresnar,
M. Greck, and R. Schmitt.
1992.
Complete nucleotide sequence of Tn1721: gene organization and a novel gene product with features of a chemotaxis protein.
Gene
111:11-20[Medline].
|
| 2.
|
Antoine, R., and C. Locht.
1992.
Isolation and molecular characterization of a novel broad-host-range plasmid from Bordetella bronchiseptica with sequence similarities to plasmids from Gram-positive organisms.
Mol. Microbiol.
6:1785-1799[Medline].
|
| 3.
|
Arico, B.,
J. F. Miller,
C. Roy,
S. Stibitz,
D. Monack,
S. Falkow,
R. Gross, and R. Rappuoli.
1989.
Sequences required for expression of Bordetella pertussis virulence factors share homology with prokaryotic signal transduction proteins.
Proc. Natl. Acad. Sci. USA
86:6671-6675[Abstract/Free Full Text].
|
| 4.
|
Beattie, D. T.,
S. Knapp, and J. J. Mekalanos.
1990.
Evidence that modulation requires sequences downstream of the promoters of two vir-repressed genes of Bordetella pertussis.
J. Bacteriol.
172:6997-7004[Abstract/Free Full Text].
|
| 5.
|
Beattie, D. T.,
M. J. Mahan, and J. J. Mekalanos.
1993.
Repressor binding to a regulatory site in the DNA coding sequence is sufficient to confer transcriptional regulation of the vir-repressed genes (vrg genes) in Bordetella pertussis.
J. Bacteriol.
175:519-527[Abstract/Free Full Text].
|
| 6.
|
Blattner, F. R.,
V. Burland,
G. Plunket,
H. J. Sofia, and D. L. Danials.
1993.
Analysis of the Escherichia coli genome. V. DNA sequence of the region from 89.2 to 92.8 minute.
Nucleic Acids Res.
21:5408-5417[Abstract/Free Full Text].
|
| 7.
|
Boucher, P. E.,
K. Murakami,
A. Ishihama, and S. Stibitz.
1997.
Nature of DNA binding and RNA polymerase interaction of the Bordetella pertussis BvgA transcriptional activator at the fha promoter.
J. Bacteriol.
179:1755-1763[Abstract/Free Full Text].
|
| 8.
|
Boucher, P. E., and S. Stibitz.
1995.
Synergistic binding of RNA polymerase and BvgA phosphate to the pertussis toxin promoter of Bordetella pertussis.
J. Bacteriol.
177:6486-6491[Abstract/Free Full Text].
|
| 9.
|
Brickman, E., and J. Beckwith.
1975.
Analysis of the regulation of Escherichia coli alkaline phosphatase synthesis using deletions and f80 transducing phages.
J. Mol. Biol.
96:307-316[Medline].
|
| 10.
|
Brown, N. L.,
S. J. Ford,
R. D. Pridmore, and D. C. Fritzinger.
1983.
Nucleotide sequence of a gene from the Pseudomonas transposon Tn501 encoding mercuric reductase.
Biochemistry
22:4089-4095[Medline].
|
| 11.
|
Brown, N. L.,
T. K. Misra,
J. N. Winnie,
A. Schmidt,
M. Seiff, and S. Silver.
1986.
The nucleotide sequence of the mercuric resistance operons of plasmid R100 and transposon Tn501: further evidence for mer genes which enhance the activity of the mercuric ion detoxification system.
Mol. Gen. Genet.
202:143-151[Medline].
|
| 12.
|
Brown, N. L.,
J. N. Winnie,
D. C. Fritzinger, and R. D. Pridmore.
1985.
The nucleotide sequence of the tnpA gene completes the sequence of the Pseudomonas transposon Tn501.
Nucleic Acids Res.
13:5657-5669[Abstract/Free Full Text].
|
| 13.
|
Brun, Y. V.,
R. Breton,
P. Lanouette, and J. Lapointe.
1990.
Precise mapping and comparison of two evolutionarily related regions of the Escherichia coli K-12 chromosome. Evolution of valU and lyst from an ancestral tRNA operon.
J. Mol. Biol.
214:825-843[Medline].
|
| 14.
|
Diver, W. P.,
J. Grinsted,
D. C. Fritzinger,
N. L. Brown,
J. Altenbuchner,
P. Rogowsky, and R. Schmitt.
1983.
DNA sequences of and complementation by the tnpR genes of Tn21, Tn501, and Tn1721.
Mol. Gen. Genet.
191:189-193[Medline].
|
| 15.
|
Finn, T. M.,
R. Shahin, and J. J. Mekalanos.
1991.
Characterization of vir-activated TnphoA gene fusions in Bordetella pertussis.
Infect. Immun.
59:3273-3279[Abstract/Free Full Text].
|
| 16.
|
Finn, T. M., and L. A. Stevens.
1995.
Tracheal colonization factor: a Bordetella pertussis secreted virulence determinant.
Mol. Microbiol.
16:625-634[Medline].
|
| 17.
|
Gerlach, G. F.,
S. Clegg, and B. L. Allen.
1989.
Identification and characterization of the genes encoding the type 3 and type 1 fimbrial adhesins of Klebsiella pneumoniae.
J. Bacteriol.
171:1262-1270[Abstract/Free Full Text].
|
| 18.
|
Griffin, H. G.,
T. J. Foster,
S. Silver, and T. K. Misra.
1987.
Cloning and DNA sequence of the mercuric and organomercuric-resistance determinants of plasmid pDU1358.
Proc. Natl. Acad. Sci. USA
84:3112-3116[Abstract/Free Full Text].
|
| 19.
|
Hall, B. G.
1997.
The rtn gene of Proteus vulgaris is actually from Escherichia coli.
J. Bacteriol.
179:2433-2434[Abstract/Free Full Text].
|
| 20.
|
Hwang, U. W.,
D. W. Lee,
C. S. Kim, and K. Chae.
1994.
Structural analysis of an rtn gene isolated from Proteus vulgaris.
Mol. Cells
4:387-391.
|
| 21.
|
Kaneko, T.,
S. Sato,
H. Kotani,
A. Tanaka,
E. Asamizu,
Y. Nakamura,
N. Miyajima,
M. Hirosawa,
M. Sugiura,
S. Sasamoto,
T. Kimura,
T. Hosouchi,
A. Matsuno,
A. Muraki,
N. Nakazaki,
K. Naruo,
S. Okumura,
S. Shimpo,
C. Takeuchi,
T. Wada,
A. Watanabe,
M. Yamada,
M. Yasuda, and S. Tabata.
1996.
Sequence analysis of the genome of the unicellular cyanobacterium Synechocystis sp. strain PCC6803. II. Sequence determination of the entire genome and assignment of potential protein coding regions.
DNA Res.
3:109-136[Abstract].
|
| 22.
|
Karimova, G.,
J. Bellalou, and A. Ullmann.
1996.
Phosphorylation-dependent binding of BvgA to the upstream region of the cyaA gene of Bordetella pertussis.
Mol. Microbiol.
20:489-496[Medline].
|
| 23.
|
Kasuga, T.,
Y. Nakase,
K. Ukishima, and K. Takatsu.
1954.
Studies on Haemophilus pertussis. V. Relation between the phase of bacilli and the progress of the whooping-cough.
Arch. Exp. Med.
27:57-62.
|
| 24.
|
Knapp, S., and J. J. Mekalanos.
1988.
Two trans-acting regulatory genes (vir and mod) control antigenic modulation in Bordetella pertussis.
J. Bacteriol.
170:5059-5066[Abstract/Free Full Text].
|
| 25.
|
Krause, M., and D. G. Guiney.
1991.
Identification of a multimer resolution system involved in stabilization of the Salmonella dublin virulence plasmid pSDL2.
J. Bacteriol.
173:5754-5762[Abstract/Free Full Text].
|
| 26.
|
Lacey, B. W.
1960.
Antigenic modulation of Bordetella pertussis.
J. Hyg.
31:423-434.
|
| 27.
|
Lamark, T.,
I. Kaasen,
M. W. Eshoo,
P. Falkenberg,
J. McDougall, and A. R. Strom.
1991.
DNA sequence and analysis of the bet genes encoding the osmoregulatory choline-glycine betaine pathway of Escherichia coli.
Mol. Microbiol.
5:1049-1064[Medline].
|
| 28.
|
LeFabvre, R. B.,
W. S. Probert, and G. C. Perng.
1993.
Characterization of a chromosomal gene and the antigen it expresses from the lyme disease agent Borrelia burgdorferi.
J. Clin. Microbiol.
31:2146-2151[Abstract/Free Full Text].
|
| 29.
|
Mazel, D.,
E. Coic,
S. Blanchard,
W. Saurin, and P. Marliere.
1997.
A survey of polypeptide deformylase function throughout the eubacterial lineage.
J. Mol. Biol.
266:939-949[Medline].
|
| 30.
|
Merkel, T. J., and S. Stibitz.
1995.
Identification of a locus required for the regulation of bvg-repressed genes in Bordetella pertussis.
J. Bacteriol.
177:2727-2736[Abstract/Free Full Text].
|
| 31.
|
Miller, J. H.
1972.
.
Experiments in molecular genetics.
Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
|
| 32.
|
Misra, T. K.,
N. L. Brown,
D. C. Fritzinger,
R. D. Pridmore,
W. M. Barnes,
L. Haberstroh, and S. Silver.
1984.
The nucleotide sequence of the mercuric resistance operons of plasmidd R100 and transposon Tn501: further evidence for mer genes which enhance the activity of the mercuric ion detoxification system.
Proc. Natl. Acad. Sci. USA
81:5975-5979[Abstract/Free Full Text].
|
| 33.
|
Mooi, F. R.
1988.
Virulence factors of Bordetella pertussis.
Antonie van Leeuwenhoek
54:465-474[Medline].
|
| 34.
|
Pawlowski, K.,
U. Klosse, and F. J. de Bruijn.
1991.
Characterization of a novel Azorhizobium caulinodans ORS571 two-componant regulatory system, NtrY/NtrX, involved in nitrogen fixation and metabolism.
Mol. Gen. Genet.
231:124-138[Medline].
|
| 35.
|
Simon, R.,
U. Priefer, and A. Puhler.
1983.
A broad host range mobilization system for in vivo genetic engineering: transposon mutagenesis in gram negative bacteria.
Bio/Technology
1:784-789.
|
| 36.
|
Sofia, H. J.,
V. Burland,
D. L. Danials,
G. Plunket, and F. R. Blattner.
1994.
Analysis of the Escherichia coli genome. IV. DNA sequence of the region from 76.0 to 81.5 minutes.
Nucleic Acids Res.
22:2576-2586[Abstract/Free Full Text].
|
| 37.
|
Stibitz, S.
1994.
Use of conditionally counterselectable suicide vectors for allelic exchange.
Methods Enzymol.
235:458-465[Medline].
|
| 38.
|
Stibitz, S.,
W. Aaronson,
D. Monack, and S. Falkow.
1989.
Phase-variation in Bordetella pertussis by Frameshift mutation in a Gene for a Novel Two-component System.
Nature
338:226-229.
|
| 39.
|
Stibitz, S., and J. F. Miller.
1994.
Coordinate regulation of virulence in Bordetella pertussis mediated by the vir (bvg) locus, p. 407-422. In
V. L. Miller, J. B. Kaper, D. A. Portnoy, and R. R. Isberg (ed.), Molecular genetics of bacterial pathogenesis.
American Society for Microbiology, Washington, D.C.
|
| 40.
|
Stibitz, S., and M. S. Yang.
1991.
Subcellular localization and immunological detection of proteins encoded by the vir locus of Bordetella pertussis.
J. Bacteriol.
173:4288-4296[Abstract/Free Full Text].
|
| 41.
|
Uhl, M. A., and J. F. Miller.
1994.
Autophosphorylation and phosphotransfer in the Bordetella pertussis BvgAS signal transduction cascade.
Proc. Natl. Acad. Sci. USA
91:1163-1167[Abstract/Free Full Text].
|
| 42.
|
Uhl, M. A., and J. F. Miller.
1995.
Bordetella pertussis BvgAS virulence control system, p. 333-349. In
J. A. Hoch, and T. J. Silhavy (ed.), Two-component signal transduction.
ASM Press, Washington, D.C.
|
| 43.
|
Weiss, A. A., and E. L. Hewlett.
1986.
Virulence factors of Bordetella pertussis.
Annu. Rev. Microbiol.
40:661-686[Medline].
|
| 44.
|
Weiss, A. A.,
E. L. Hewlett,
A. Meyers, and S. Falkow.
1983.
Tn5-induced mutations affecting virulence factors of Bordetella pertussis.
Infect. Immun.
42:33-41[Abstract/Free Full Text].
|
| 45.
|
Weiss, A. A.,
A. R. Melton,
K. E. Walker,
C. Andraos-Selim, and J. J. Meidl.
1989.
Use of the promoter fusion transposon Tn5lac to identify mutations in Bordetella pertussis vir-regulated genes.
Infect. Immun.
57:2674-2682[Abstract/Free Full Text].
|
| 46.
|
Yamamoto, Y.,
H. Aiba,
T. Baba,
K. Hayashi,
T. Inada,
K. Isono,
T. Itoh,
S. Kimura,
M. Kitagawa,
K. Makino,
T. Miki,
N. Mitsuhashi,
K. Mizobuchi,
H. Mori,
S. Nakade,
Y. Nakamura,
H. Nashimoto,
T. Oshima,
S. Oyama,
N. Saito,
G. Sampei,
Y. Satoh,
S. Sivasundaram,
H. Tagami,
H. Takahashi,
J. Takeda,
K. Takemoto,
K. Uehara,
C. Wada,
S. Yamagata, and T. Horiuchi.
1997.
Construction of a contiguous 874 kb sequence of the Escherichia coli K-12 genome corresponding to 50.0-68.8 min region on the linkage map and analysis of its sequence features.
DNA Res.
4:91-113[Abstract].
|
J Bacteriol, April 1998, p. 1682-1690, Vol. 180, No. 7
0021-9193/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Ryan, R. P., Fouhy, Y., Lucey, J. F., Dow, J. M.
(2006). Cyclic Di-GMP Signaling in Bacteria: Recent Advances and New Puzzles. J. Bacteriol.
188: 8327-8334
[Full Text]
-
Kulasakara, H., Lee, V., Brencic, A., Liberati, N., Urbach, J., Miyata, S., Lee, D. G., Neely, A. N., Hyodo, M., Hayakawa, Y., Ausubel, F. M., Lory, S.
(2006). Analysis of Pseudomonas aeruginosa diguanylate cyclases and phosphodiesterases reveals a role for bis-(3'-5')-cyclic-GMP in virulence. Proc. Natl. Acad. Sci. USA
103: 2839-2844
[Abstract]
[Full Text]
-
Erova, T. E., Pillai, L., Fadl, A. A., Sha, J., Wang, S., Galindo, C. L., Chopra, A. K.
(2006). DNA Adenine Methyltransferase Influences the Virulence of Aeromonas hydrophila. Infect. Immun.
74: 410-424
[Abstract]
[Full Text]
-
Stenson, T. H., Allen, A. G., al-Meer, J. A., Maskell, D., Peppler, M. S.
(2005). Bordetella pertussis risA, but Not risS, Is Required for Maximal Expression of Bvg-Repressed Genes. Infect. Immun.
73: 5995-6004
[Abstract]
[Full Text]
-
Julio, S. M., Cotter, P. A.
(2005). Characterization of the Filamentous Hemagglutinin-Like Protein FhaS in Bordetella bronchiseptica. Infect. Immun.
73: 4960-4971
[Abstract]
[Full Text]
-
Mattoo, S., Cherry, J. D.
(2005). Molecular Pathogenesis, Epidemiology, and Clinical Manifestations of Respiratory Infections Due to Bordetella pertussis and Other Bordetella Subspecies. Clin. Microbiol. Rev.
18: 326-382
[Abstract]
[Full Text]
-
Croinin, T. O., Grippe, V. K., Merkel, T. J.
(2005). Activation of the vrg6 Promoter of Bordetella pertussis by RisA. J. Bacteriol.
187: 1648-1658
[Abstract]
[Full Text]
-
Kuchma, S. L., Connolly, J. P., O'Toole, G. A.
(2005). A Three-Component Regulatory System Regulates Biofilm Maturation and Type III Secretion in Pseudomonas aeruginosa. J. Bacteriol.
187: 1441-1454
[Abstract]
[Full Text]
-
D'Argenio, D. A., Miller, S. I.
(2004). Cyclic di-GMP as a bacterial second messenger. Microbiology
150: 2497-2502
[Abstract]
[Full Text]
-
Merkel, T. J., Boucher, P. E., Stibitz, S., Grippe, V. K.
(2003). Analysis of bvgR Expression in Bordetella pertussis. J. Bacteriol.
185: 6902-6912
[Abstract]
[Full Text]
-
Spears, P. A., Temple, L. M., Miyamoto, D. M., Maskell, D. J., Orndorff, P. E.
(2003). Unexpected Similarities between Bordetella avium and Other Pathogenic Bordetellae. Infect. Immun.
71: 2591-2597
[Abstract]
[Full Text]
-
D'Argenio, D. A., Calfee, M. W., Rainey, P. B., Pesci, E. C.
(2002). Autolysis and Autoaggregation in Pseudomonas aeruginosa Colony Morphology Mutants. J. Bacteriol.
184: 6481-6489
[Abstract]
[Full Text]
-
Boucher, P. E., Yang, M.-S., Schmidt, D. M., Stibitz, S.
(2001). Genetic and Biochemical Analyses of BvgA Interaction with the Secondary Binding Region of the fha Promoter of Bordetella pertussis. J. Bacteriol.
183: 536-544
[Abstract]
[Full Text]
-
Antoine, R., Alonso, S., Raze, D., Coutte, L., Lesjean, S., Willery, E., Locht, C., Jacob-Dubuisson, F.
(2000). New Virulence-Activated and Virulence-Repressed Genes Identified by Systematic Gene Inactivation and Generation of Transcriptional Fusions in Bordetella pertussis. J. Bacteriol.
182: 5902-5905
[Abstract]
[Full Text]
-
Merkel, T. J., Stibitz, S., Keith, J. M., Leef, M., Shahin, R.
(1998). Contribution of Regulation by the bvg Locus to Respiratory Infection of Mice by Bordetella pertussis. Infect. Immun.
66: 4367-4373
[Abstract]
[Full Text]